Literature DB >> 18208852

Complications after lung radiofrequency ablation: risk factors for lung inflammation.

M Nomura1, K Yamakado, Y Nomoto, A Nakatsuka, N Ii, H Takaki, Y Yamashita, K Takeda.   

Abstract

This retrospective study was conducted to review the complications of lung radiofrequency (RF) ablation and to clarify the effects of inflammation after lung RF ablation on mortality and morbidity. Complications were evaluated by reviewing medical records on an RF session basis. The C-reactive protein (CRP) value was used as an indicator of inflammation and was measured before and every 1-2 days during the hospital stay after RF ablation. The relationships between CRP values and patient baselines were evaluated to identify factors affecting lung inflammation. 130 patients who underwent 327 lung RF ablation sessions were enrolled in this study. The major complication rate was 18.3% (60/327). Inflammation-related complications such as interstitial pneumonia (n = 2) and aseptic pleuritis (n = 2) developed in four sessions (1.2%). Death occurred in two patients with interstitial pneumonia (0.6%). The mean CRP value increased significantly from 1.3+/-2.6 mg dl(-1) to 3.4+/-5.6 mg dl(-1) (p<0.01) after RF ablation. Large tumour size (>or=2 cm) and previous external-beam radiotherapy were significant factors associated with an increased CRP value in both univariate and multivariate analyses. In conclusion, although the incidence rate is low, fatal lung inflammation may develop after lung RF ablation. Large tumour size and previous external-beam radiotherapy are risk factors for severe lung inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208852     DOI: 10.1259/bjr/84269673

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  18 in total

1.  Rupture of benign thyroid tumors after radio-frequency ablation.

Authors:  J H Shin; S L Jung; J H Baek; J-H Kim
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

Review 2.  Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances.

Authors:  S L Smith; P E Jennings
Journal:  Br J Radiol       Date:  2014-12-03       Impact factor: 3.039

Review 3.  Alternative to surgery in early stage NSCLC-interventional radiologic approaches.

Authors:  Kyungmouk Steve Lee; Bradley B Pua
Journal:  Transl Lung Cancer Res       Date:  2013-10

4.  Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms.

Authors:  Matthew J Howenstein; Kent T Sato
Journal:  Semin Intervent Radiol       Date:  2010-09       Impact factor: 1.513

5.  Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller.

Authors:  Satoru Ochiai; Koichiro Yamakado; Hiroshi Kodama; Yoshihito Nomoto; Noriko Ii; Haruyuki Takaki; Hajime Sakuma
Journal:  Int J Clin Oncol       Date:  2014-08-19       Impact factor: 3.402

Review 6.  Complications of microwave and radiofrequency lung ablation: personal experience and review of the literature.

Authors:  G Carrafiello; M Mangini; F Fontana; A Di Massa; A M Ierardi; E Cotta; F Piacentino; L Nocchi Cardim; C Pellegrino; C Fugazzola
Journal:  Radiol Med       Date:  2011-10-21       Impact factor: 3.469

Review 7.  Lung cancer ablation: complications.

Authors:  Takao Hiraki; Hideo Gobara; Hiroyasu Fujiwara; Hiroaki Ishii; Koji Tomita; Mayu Uka; Satoko Makimoto; Susumu Kanazawa
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

8.  Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10.

Authors:  Joseph P Erinjeri; Contessa T Thomas; Alaiksandra Samoilia; Martin Fleisher; Mithat Gonen; Constantinos T Sofocleous; Raymond H Thornton; Robert H Siegelbaum; Anne M Covey; Lynn A Brody; William Alago; Majid Maybody; Karen T Brown; George I Getrajdman; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2013-04-10       Impact factor: 3.464

9.  Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer.

Authors:  T Schneider; A Sevko; C P Heussel; L Umansky; P Beckhove; H Dienemann; S Safi; J Utikal; H Hoffmann; V Umansky
Journal:  Clin Exp Immunol       Date:  2015-04-15       Impact factor: 4.330

Review 10.  Radiofrequency thermocoagulation of lung tumours. Where we are, where we are headed.

Authors:  F M Gómez; J Palussière; E Santos; T Tourdias; F Cornélis; V Sáiz; H Montes; O Eker
Journal:  Clin Transl Oncol       Date:  2009-01       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.